3 trends I believe could impact stock markets in 2022

2021 was a year when macros dominated stock market performance, according to Manika Premsingh. Will the pattern repeat in 2022?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

There is no denying the impact that macro trends and events have on stock markets. We have seen that in the last two years. One of the biggest examples of this is the fiscal stimulus of recent times. In a bid to battle the impact of lockdowns, governments around the world supported business in various ways, including by pumping money into the economic system. This resulted in a global rise in commodity prices and closer to home, in a property market rally. As these fiscal stimuli are being withdrawn, we are already witnessing softening in these sectors. And in 2022, I expect three such big trends to impact the stock markets. 

Inflation will remain high

Perhaps the most obvious of these is inflation. Price rises have been accelerating through the year. As lockdowns were eased, there was sidden, higher demand for products and services. And the mismatch with supply increased prices. Along with this, oil prices have also been on a tear. And since these are inescapable costs, a lot of listed companies have talked about cost increases when releasing their results. The trend is expected to continue in 2022 as well. And that means it could be a drag on broader stock markets next year. But I bought oil producers’ stocks like BP and Royal Dutch Shell to counteract the impact of inflation on my portfolio. And I intend to continue holding them through next year.

Interest rates to rise

As a result of rising inflation, interest rates are also expected to continue heading upwards. In fact, they have started rising already. The Bank of England recently reacted to a spike in inflation by increasing its interest rate by 0.15 percentage points to 0.25%. Commercial banks could follow suit. This would be bad news for indebted companies, of which there are many (big and small) in the post-pandemic environment, as it means their debt-servicing costs will rise. But it is also a positive for segments like banking. The banks have suffered quite a bit during the pandemic. My picks among the major FTSE 100 names include Lloyds Bank and HSBC, which are on my investing wishlist for 2022. 

Slow recovery could impact stock markets

Last but not least, is the impact of these trends on the global recovery. The economic recovery has already been quite slow in 2021. And to that if I add continued pandemic-related concerns, high inflation and rising interest rates, I think it is fair to expect that the recovery may not exactly be a boom. In fact, it could continue to be tepid. And that to me is a sign to consider defensives closely like healthcare and pharmaceutical companies. I have been a happy investor in AstraZeneca for instance and recently even increased my holding. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Manika Premsingh owns AstraZeneca, BP, and Royal Dutch Shell B. The Motley Fool UK has recommended HSBC Holdings and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »